Artwork
iconShare
 
Manage episode 346102507 series 3380302
Content provided by Hepatitis B Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hepatitis B Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

On this episode B Heppy we sit down with Dr. Mike Sofia, Co-founder and Chief Scientific Officer at Arbutus Biopharma to talk about his company's work on hepatitis B curative therapies. Listen and learn more about the pre-clinical process.
Resources:
Arbutus Biopharma
Drug Watch
Clinical Trial Finder

Support the show

Our website: www.hepb.org
Support B Heppy!
Social Media: Instagram - Twitter - Facebook

  continue reading

66 episodes